A detailed history of Armstrong Advisory Group, Inc transactions in Haleon PLC stock. As of the latest transaction made, Armstrong Advisory Group, Inc holds 1,542 shares of HLN stock, worth $14,479. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,542
Previous 1,615 4.52%
Holding current value
$14,479
Previous $13,000 23.08%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$8.32 - $10.7 $607 - $781
-73 Reduced 4.52%
1,542 $16,000
Q2 2024

Jul 12, 2024

BUY
$8.01 - $8.64 $5,054 - $5,451
631 Added 64.13%
1,615 $13,000
Q4 2023

Jan 17, 2024

BUY
$7.78 - $8.62 $2,209 - $2,448
284 Added 40.57%
984 $8,000
Q4 2022

Jan 17, 2023

BUY
$5.96 - $8.06 $4,172 - $5,642
700 New
700 $0

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.4B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Armstrong Advisory Group, Inc Portfolio

Follow Armstrong Advisory Group, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armstrong Advisory Group, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Armstrong Advisory Group, Inc with notifications on news.